Literature DB >> 33290647

Trends in Cardiovascular Complications and Mortality among Patients with Diabetes in South Korea.

Jung Hwan Park1, Kyoung Hwa Ha2,3, Bo Yeon Kim4, Jae Hyuk Lee5, Dae Jung Kim2,3.   

Abstract

We investigated the cardiovascular complications and mortality rates of patients with diabetes in South Korea. The rates of hospitalization due to cardiovascular complications and mortality were analyzed using the Korean National Health Insurance Service-National Sample Cohort. From 2006 to 2015, the rates of hospitalization due to major cardiovascular complications decreased, while those due to heart failure (from 72 to 146 and 124 to 161 per 10,000 men and women, respectively) and peripheral artery disease (from 39 to 55 and 19 to 35 per 10,000 men and women, respectively) increased. In the period 2007 to 2015, the mortality rates for cancer, cerebrovascular disease, diabetes, heart disease, and hypertensive disease all decreased. However, the mortality rate for pneumonia increased. We observed a continuous reduction in cardiovascular complications and mortality in adults with diabetes. However, with the increase in some diabetes complications, more efforts are needed to prevent diabetes complications.

Entities:  

Keywords:  Cardiovascular disease; Diabetes mellitus; Epidemiology; Mortality

Mesh:

Year:  2020        PMID: 33290647      PMCID: PMC7850871          DOI: 10.4093/dmj.2020.0175

Source DB:  PubMed          Journal:  Diabetes Metab J        ISSN: 2233-6079            Impact factor:   5.376


Graphical abstract

INTRODUCTION

Diabetes is known to be associated with cardiovascular disease (CVD) morbidity and mortality [1]. Unlike the increased prevalence of diabetes itself, the incidence of CVD and CVD-related mortality among patients with diabetes have decreased significantly over the past two decades [2]. This study was aimed to investigate the rates of cardiovascular complications and mortality among Korean adults (aged ≥30 years) with diabetes by analyzing the data of the National Health Insurance Service-National Sample Cohort (NHIS-NSC).

METHODS

Data source and study design

The NHIS-NSC enrolled 1,021,208 individuals (2.2% of the total eligible Korean population in 2006) using a systematic sampling method. Detailed information on the NHIS-NSC can be found elsewhere [3]. The protocol of this study was approved by the Institutional Review Board of Ajou University Hospital, Suwon, Korea (approval No. AJIRB-MED-EXP-19-347) and the requirement for informed consent was waived. For each calendar year, we identified individuals with diabetes aged 30 years or older. Diabetes was defined as diagnosed with E10–E14 codes of the 10th edition of the International Classification of Diseases (ICD-10) more than twice, or when a patient had a prescription for oral glucose-lowering medications (Anatomical Therapeutic Chemical [ATC] code A10B) for more than 30 days, or (in outpatients) a prescription for insulin (ATC code A10A).

Definitions of cardiovascular complications and mortality

We identified patients hospitalized due to six diabetes-related cardiovascular complications, namely ischemic heart disease, myocardial infarction, heart failure, hemorrhagic stroke, ischemic stroke, and peripheral artery disease (PAD), based on ICD-10 and procedure codes that contributes to clinically hospitalizations regardless of the principal reason for hospitalization (Supplementary Table 1). Information on the date and underlying cause of death was obtained from the National Death Registry using unique resident registration numbers. Causes of death were identified based on ICD-10 codes. There were six mutually exclusive cause of death categories (Supplementary Table 1).

Statistical analysis

We calculated the rates of hospitalization due to cardiovascular complications separately for each year by dividing the number of patients hospitalized for cardiovascular complications by the corresponding number of patients with diabetes for that year. For each calendar year, hospitalization rates were expressed as age-standardized rates per 10,000 individuals; mortality rates were expressed as age-standardized rates per 100,000 individuals, separately for men and women. The rates were age-standardized according to the weighted distribution of the 2011 population, across sexes and 5-year age groups from 30 to 34 years up to 85 years and above. All statistical analyses were performed using SAS software version 9.4 (SAS Institute Inc., Cary, NC, USA).

RESULTS

Hospitalization rate for cardiovascular complications

In the period 2006 to 2015, the hospitalization rates due to major cardiovascular complications (ischemic heart disease, ischemic stroke, and myocardial infarction) all decreased. There was a decreasing trend in ischemic heart disease rates (from 438 to 461 and 419 to 397 per 10,000 men and women with diabetes, respectively), ischemic stroke rates (from 257 to 205 and 257 to 204 per 10,000 men and women with diabetes, respectively), and myocardial infarction rates (from 111 to 81 and 97 to 60 per 10,000 men and women with diabetes, respectively). There was a slight increase in the hemorrhagic stroke rates (from 38 to 46 and 44 to 51 per 10,000 men and women with diabetes, respectively) (Fig. 1, Supplementary Table 2).
Fig. 1

Rates of hospitalization due to cardiovascular complications among men (A) and women (B) with diabetes in South Korea (2006 to 2015).

However, increasing rates of heart failure (from 72 to 146 and 124 to 161 per 10,000 men and women with diabetes, respectively) and PAD (from 39 to 55 and 19 to 35 per 10,000 men and women with diabetes, respectively) were seen (Fig. 1, Supplementary Table 2). The hospitalization rates for revascularization slightly decreased or remained the same (percutaneous coronary intervention, from 97 to 95 and 56 to 50 per 10,000 men and women with diabetes, respectively; coronary artery bypass surgery from 11 to 7 and 4 to 4 per 10,000 men and women with diabetes, respectively) (Supplementary Table 2).

Mortality rate and cause of death in patients with diabetes

In 2007 to 2015, the mortality rate decreased in both men and women (from 2,599 to 2,010 and 1,939 to 1,662 per 100,000 adults with diabetes, respectively) (Supplementary Table 3). The mortality rates for cancer, cerebrovascular disease, diabetes, heart disease, and hypertensive disease decreased in both men and women. However, the mortality rates due to pneumonia increased in both men and women (from 22 to 93 and 34 to 79 per 100,000 adults with diabetes, respectively) (Fig. 2, Supplementary Table 3).
Fig. 2

Mortality rates among men (A) and women (B) with diabetes in South Korea (2007 to 2015).

"Updated on 25 March 2021"

In 2015, the six leading causes of death accounted for 66.7% of all deaths in Korean adults with diabetes (cancer, 30.3%; diabetes, 10.5%; heart disease, 10.5%; cerebrovascular disease, 8.9%; pneumonia, 5.0%; and hypertensive disease, 1.5%) (Supplementary Fig. 1). The five most common causes of cancer deaths were lung, liver, colorectal, pancreas, and stomach cancer (Supplementary Table 4).

DISCUSSION

The rates of hospitalization due to major cardiovascular complications and deaths caused by vascular disease and cancer decreased among adult (aged ≥30 years) with diabetes in Korea. These findings are consistent with previous study in Korea [4]. In patients with diabetes, the proportion of patients with good glycemic control remains less than half of them, while the proportion of patients with extremely poor glycemic control is dramatically decreasing [5]. In addition, the overall improvement of cardiovascular risk factors management such as blood pressure, smoking, and lipid level and proper treatment of cardiovascular events and the regular national cancer screening program in Korea is related with the decrease in mortality in patients with diabetes [6-9]. The hospitalization rate for heart failure increased. Better preventive treatments of cardiovascular risk factors may also have contributed to the reduced risk of developing heart failure [10]. However, paradoxically, due to ageing and the development of treatments that allow increased survival after acute heart insults or with chronic cardiac abnormalities, number of patients with heart failure increased [11]. In Korea, appropriate treatment by the certification system for cardiovascular intervention institute/specialist since 2011, efforts to improve awareness of early symptoms, decreasing of the proportion of ST-elevation myocardial infarction led to a decrease in the case-fatality in hospitalized acute myocardial infarction patients from 2007 to 2016 [12]. Also, according to the Korean hospitalized heart failure registry, the development of cardiovascular treatment has increased the survival rate of acute coronary syndrome, as a result, ischemic heart disease is a major cause of hospitalized for heart failure [13]. In addition, the prevalence of heart failure increased with age, and the proportion of patients with diabetes has increased [13,14]. PAD also increased slightly. Recent meta-analysis reported that the prevalence of PAD increased from 2000 to 2010 in high-income countries due to an ageing population [15]. However, in this study, the outcome events were ascertained from health insurance claims data, and diagnoses were not adjudicated by medical records. In addition, using diagnoses code will tend to result in higher observed incidence and prevalence. Thus, to increase accuracy of diagnoses in claim database, we restricted patients undergoing PAD-related procedures and surgery. Recently, the advance of new technology of peripheral angiography has led to an increase of PAD-related procedures and surgery. Thus, the increase of PAD is partly due to the diagnosis of hidden patients with PAD. In Korea, using the database of the NHIS, amputation involving diabetic foot based on vascular interventions for PAD steadily increased from 2011 to 2016, particularly in minor amputations [16]. During the study period from 2004 to 2013, endovascular revascularization including balloon angioplasty, stent placement, and percutaneous atherectomy increased, while open revascularization such as bypass with artificial graft and autologous vein decreased. This study suggested that the endovascular revascularization for PAD treatment expanded by ageing, increasing number of patients with diabetes and chronic kidney disease on hemodialysis—risk factors for the development of PAD, and repeated interventions for maintaining reasonable clinical outcomes [17]. Deaths from pneumonia also increased. The increased risk of intensive care unit hospitalization and death due to pneumonia in diabetes patients have been reported [18]. In diabetes, impaired immune response is associated with hyperglycemia, and hospitalization for hyperglycemia has been shown to increase the risk of pneumonia-related mortality [19,20]. In conclusion, the present study revealed a decrease in the rates of cardiovascular complications and mortality, among Korean adults with diabetes, which may reflect advances in diabetes care. However, the hospitalization rates for heart failure and PAD and the mortality rates for pneumonia increased. Thus, more efforts are needed to prevent diabetes complications.
  19 in total

1.  Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea.

Authors:  Juneyoung Lee; Ji Sung Lee; Sook-Hee Park; Soon Ae Shin; KeeWhan Kim
Journal:  Int J Epidemiol       Date:  2017-04-01       Impact factor: 7.196

2.  National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008.

Authors:  Jersey Chen; Sharon-Lise T Normand; Yun Wang; Harlan M Krumholz
Journal:  JAMA       Date:  2011-10-19       Impact factor: 56.272

3.  Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.

Authors:  Aidin Rawshani; Araz Rawshani; Stefan Franzén; Björn Eliasson; Ann-Marie Svensson; Mervete Miftaraj; Darren K McGuire; Naveed Sattar; Annika Rosengren; Soffia Gudbjörnsdottir
Journal:  N Engl J Med       Date:  2017-04-13       Impact factor: 91.245

4.  Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis.

Authors:  Peige Song; Diana Rudan; Yajie Zhu; Freya J I Fowkes; Kazem Rahimi; F Gerald R Fowkes; Igor Rudan
Journal:  Lancet Glob Health       Date:  2019-08       Impact factor: 26.763

5.  Admission Hyperglycemia in Critically Ill Sepsis Patients: Association With Outcome and Host Response.

Authors:  Lonneke A van Vught; Maryse A Wiewel; Peter M C Klein Klouwenberg; Arie J Hoogendijk; Brendon P Scicluna; David S Y Ong; Olaf L Cremer; Janneke Horn; Marc M J Bonten; Marcus J Schultz; Tom van der Poll
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

Review 6.  The impact of diabetes on the pathogenesis of sepsis.

Authors:  G C K W Koh; S J Peacock; T van der Poll; W J Wiersinga
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-30       Impact factor: 3.267

Review 7.  Current status of managing diabetes mellitus in Korea.

Authors:  Kyoung Hwa Ha; Dae Jung Kim
Journal:  Korean J Intern Med       Date:  2016-09-01       Impact factor: 2.884

8.  Prevalence, Awareness, Treatment, and Control of Hypertension in Korea.

Authors:  Si-Hyuck Kang; Sun-Hwa Kim; Jun Hwan Cho; Chang-Hwan Yoon; Seung-Sik Hwang; Hae-Young Lee; Tae-Jin Youn; In-Ho Chae; Cheol-Ho Kim
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

9.  Long-term trends in smoking prevalence and its socioeconomic inequalities in Korea, 1992-2016.

Authors:  Youngs Chang; Hee-Yeon Kang; Dohee Lim; Hong-Jun Cho; Young-Ho Khang
Journal:  Int J Equity Health       Date:  2019-09-18

10.  Impact of diabetes on cardiovascular disease: an update.

Authors:  Alessandra Saldanha de Mattos Matheus; Lucianne Righeti Monteiro Tannus; Roberta Arnoldi Cobas; Catia C Sousa Palma; Carlos Antonio Negrato; Marilia de Brito Gomes
Journal:  Int J Hypertens       Date:  2013-03-04       Impact factor: 2.420

View more
  10 in total

Review 1.  Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management.

Authors:  Cheng-Xu Ma; Xiao-Ni Ma; Cong-Hui Guan; Ying-Dong Li; Dídac Mauricio; Song-Bo Fu
Journal:  Cardiovasc Diabetol       Date:  2022-05-14       Impact factor: 8.949

2.  Diabetes Fact Sheet in Korea 2021.

Authors:  Jae Hyun Bae; Kyung-Do Han; Seung-Hyun Ko; Ye Seul Yang; Jong Han Choi; Kyung Mook Choi; Hyuk-Sang Kwon; Kyu Chang Won
Journal:  Diabetes Metab J       Date:  2022-05-25       Impact factor: 5.893

Review 3.  Interpreting global trends in type 2 diabetes complications and mortality.

Authors:  Mohammed K Ali; Jonathan Pearson-Stuttard; Elizabeth Selvin; Edward W Gregg
Journal:  Diabetologia       Date:  2021-11-27       Impact factor: 10.122

4.  Editorial: Management of Diabetes and its Complications: A Focus on Endothelial Dysfunction.

Authors:  Shanhu Qiu; Jianhua Ma; Tongzhi Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-18       Impact factor: 5.555

5.  Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines.

Authors:  Soo Jin Yun; In-Kyung Jeong; Jin-Hye Cha; Juneyoung Lee; Ho Chan Cho; Sung Hee Choi; SungWan Chun; Hyun Jeong Jeon; Ho-Cheol Kang; Sang Soo Kim; Seung-Hyun Ko; Gwanpyo Koh; Su Kyoung Kwon; Jae Hyuk Lee; Min Kyong Moon; Junghyun Noh; Cheol-Young Park; Sungrae Kim
Journal:  Diabetes Metab J       Date:  2022-03-03       Impact factor: 5.893

Review 6.  Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus.

Authors:  Jeongmin Lee; Jae-Seung Yun; Seung-Hyun Ko
Journal:  Nutrients       Date:  2022-07-27       Impact factor: 6.706

Review 7.  Renoprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors: Focusing on Renal Hemodynamics.

Authors:  Nam Hoon Kim; Nan Hee Kim
Journal:  Diabetes Metab J       Date:  2022-07-27       Impact factor: 5.893

8.  Trends in diabetes-related complications in Singapore, 2013-2020: A registry-based study.

Authors:  Joshua Kuan Tan; Nur Nasyitah Mohamed Salim; Gek Hsiang Lim; Sing Yi Chia; Julian Thumboo; Yong Mong Bee
Journal:  PLoS One       Date:  2022-10-11       Impact factor: 3.752

Review 9.  Blood Pressure Target in Type 2 Diabetes Mellitus.

Authors:  Hyun-Jin Kim; Kwang-Il Kim
Journal:  Diabetes Metab J       Date:  2022-09-19       Impact factor: 5.893

10.  Cardiovascular disease in patients with type 2 diabetes.

Authors:  Ja Young Jeon; Dae Jung Kim
Journal:  J Diabetes Investig       Date:  2022-01-19       Impact factor: 3.681

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.